Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3355 |
|
| Actual shortage: | 217 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
61 (25%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-AMLODIPINE | 5.0MG | TABLET | Resolved | 2017-09-26 | 2017-10-03 | 23533 |
| APO-AMLODIPINE | 10.0MG | TABLET | Resolved | 2017-12-12 | 2018-01-24 | 32511 |
| APO-AMLODIPINE | 5.0MG | TABLET | Resolved | 2018-01-10 | 2018-04-19 | 35536 |
| APO-AMLODIPINE | 10.0MG | TABLET | Resolved | 2018-03-05 | 2018-08-14 | 41847 |
| APO-AMLODIPINE | 5.0MG | TABLET | Resolved | 2018-03-13 | 2018-04-19 | 42669 |
| APO-AMLODIPINE | 5.0MG | TABLET | Resolved | 2018-05-02 | 2018-07-25 | 47963 |
| APO-AMLODIPINE | 5.0MG | TABLET | Resolved | 2018-08-09 | 2018-09-29 | 57766 |
| APO-AMLODIPINE | 10.0MG | TABLET | Resolved | 2018-08-27 | 2018-10-19 | 59287 |
| APO-AMLODIPINE | 5.0MG | TABLET | Resolved | 2019-10-09 | 2019-12-09 | 95821 |
| APO-AMLODIPINE | 5.0MG | TABLET | Resolved | 2019-12-05 | 2019-12-16 | 100203 |
| APO-AMLODIPINE | 5.0MG | TABLET | Resolved | 2020-07-23 | 2020-08-07 | 120979 |
| APO-AMLODIPINE-ATORVASTATIN | 10MG 40MG | TABLET | Resolved | 2019-12-12 | 2020-01-15 | 101082 |
| APO-AMLODIPINE-ATORVASTATIN | 10MG 80MG | TABLET | Resolved | 2019-12-12 | 2020-01-22 | 101088 |
| APO-AMLODIPINE-ATORVASTATIN | 10MG 10MG | TABLET | Resolved | 2020-07-08 | 2020-07-13 | 119677 |
| APO-AMLODIPINE-ATORVASTATIN | 10MG 40MG | TABLET | Resolved | 2020-07-08 | 2020-07-13 | 119683 |
| APO-AMLODIPINE-ATORVASTATIN | 10MG 80MG | TABLET | Resolved | 2020-07-08 | 2020-07-13 | 119687 |
| APO-AMLODIPINE-ATORVASTATIN | 5MG 80MG | TABLET | Resolved | 2020-07-08 | 2020-07-13 | 119690 |
| APO-AMLODIPINE-ATORVASTATIN | 80MG 5MG | TABLET | Resolved | 2023-07-07 | 2023-09-01 | 197872 |
| APO-AMLODIPINE-ATORVASTATIN | 80MG 10MG | TABLET | Resolved | 2023-12-08 | 2024-01-19 | 212940 |
| APO-AMLODIPINE-ATORVASTATIN | 10MG 80MG | TABLET | Resolved | 2021-01-29 | 2021-05-26 | 132703 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-FENTANYL MATRIX | 100MCG | PATCH | Discontinued | 2018-02-23 | 2018-12-28 | 40741 |
| APO-FENTANYL MATRIX | 25MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60489 |
| APO-FENTANYL MATRIX | Discontinued | 2018-09-07 | 2018-09-15 | 60494 | ||
| APO-FENTANYL MATRIX | 75MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60497 |
| APO-FLUNISOLIDE NASAL SPRAY | 0.25MG | METERED-DOSE PUMP | Discontinued | 2018-02-26 | 2018-02-26 | 40965 |
| APO-FLUVOXAMINE | 100MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4713 |
| APO-FLUVOXAMINE | 50MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4716 |
| APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2019-01-02 | 2019-01-02 | 70815 |
| APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2018-02-26 | 2018-02-26 | 40997 |
| APO-GEMFIBROZIL | 600MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4927 |
| APO-GEMFIBROZIL CAP 300MG USP | 300MG | CAPSULE | Discontinued | 2017-03-31 | 2018-12-07 | 4920 |
| APO-GEMFIBROZIL CAP 300MG USP | Discontinued | 2019-06-12 | 2019-06-12 | 86557 | ||
| APO-GLICLAZIDE | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60512 |
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94452 | ||
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94446 | ||
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94449 | ||
| APO-HALOPERIDOL TAB 2MG | 2MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1084 |
| APO-HALOPERIDOL TAB 5MG | 5MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1087 |
| APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
| APO-HYDROMORPHONE CR | 6MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110959 |